These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12734923)

  • 1. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
    Mittal G; Udwadia Z; Joshi VR
    J Rheumatol; 2003 May; 30(5):1121-2; author reply 1122. PubMed ID: 12734923
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
    Casale R; Generini S; Luppi F; Pignone A; Matucci-Cerinic M
    Arthritis Rheum; 2004 Aug; 51(4):665-9. PubMed ID: 15334442
    [No Abstract]   [Full Text] [Related]  

  • 4. Fixed drug eruption induced by cyclophosphamide.
    Sakurai K; Otsuka A; Miyachi Y; Kabashima K
    Eur J Dermatol; 2012; 22(3):401-2. PubMed ID: 22378104
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse events during the Scleroderma Lung Study.
    Furst DE; Tseng CH; Clements PJ; Strange C; Tashkin DP; Roth MD; Khanna D; Li N; Elashoff R; Schraufnagel DE;
    Am J Med; 2011 May; 124(5):459-67. PubMed ID: 21531236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?
    Wells AU; Latsi P; McCune WJ
    Am J Respir Crit Care Med; 2007 Nov; 176(10):952-3. PubMed ID: 17984310
    [No Abstract]   [Full Text] [Related]  

  • 7. Dexamethasone-cyclophosphamide pulse therapy in systemic sclerosis: A retrospective study from a tertiary care hospital.
    Dogra D; Dogra N; Gupta G; Mushtaq S
    Indian J Dermatol Venereol Leprol; 2017; 83(4):494-496. PubMed ID: 28540872
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic sclerosis and dexamethasone cyclophosphamide pulse therapy.
    Pasricha JS
    Indian J Dermatol Venereol Leprol; 2009; 75(5):510-1; author reply 514. PubMed ID: 19736435
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease.
    Kowal-Bielecka O; Distler O; Kowal K; Siergiejko Z; Chwiećko J; Sulik A; Gay RE; Łukaszyk AB; Gay S; Sierakowski S
    Arthritis Rheum; 2003 Jun; 48(6):1639-46. PubMed ID: 12794832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide.
    Lorenzi AR; Johnson AH; Davies G; Gough A
    Ann Rheum Dis; 2001 Aug; 60(8):796-8. PubMed ID: 11454645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
    Abignano G; Bissell LA; Emery P; Del Galdo F; Buch MH
    Rheumatology (Oxford); 2016 Dec; 55(12):2273-2275. PubMed ID: 27744357
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis.
    White B; Moore WC; Wigley FM; Xiao HQ; Wise RA
    Ann Intern Med; 2000 Jun; 132(12):947-54. PubMed ID: 10858177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy.
    Ostojic P; Damjanov N
    Clin Rheumatol; 2006 Nov; 25(6):819-21. PubMed ID: 16440134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases.
    Takahashi T; Asano Y; Amiya E; Hatano M; Tamaki Z; Ozeki A; Watanabe A; Kawarasaki S; Nakao T; Taniguchi T; Ichimura Y; Toyama T; Watanabe M; Hirata Y; Nagai R; Sato S
    Mod Rheumatol; 2012 Aug; 22(4):598-601. PubMed ID: 22015621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scleromyxedema: immunosuppressive therapy with cyclophosphamide].
    Aberer W; Wolff K
    Hautarzt; 1988 May; 39(5):277-80. PubMed ID: 3403262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide.
    Musette P; Pascal F; Hoang-Xuan T; Heller M; Lok C; Deboise A; Dubertret L; Prost C
    Arch Dermatol; 2001 Jan; 137(1):101-2. PubMed ID: 11176680
    [No Abstract]   [Full Text] [Related]  

  • 17. [So-called immunosuppressive cytotoxic medication in acute disseminated lupus erythematosus and scleroderma].
    Thivolet J; Perrot H
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):412-4. PubMed ID: 5510738
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.
    Yiannopoulos G; Pastromas V; Antonopoulos I; Katsiberis G; Kalliolias G; Liossis SN; Andonopoulos AP
    Rheumatol Int; 2007 Feb; 27(4):357-61. PubMed ID: 17021713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachial plexopathy associated with diffuse edematous scleroderma.
    Mouthon L; Halimi C; Dussaule Md JC; Cayre-Castel Md M; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):303-5. PubMed ID: 10922959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.
    Kowal-Bielecka O; Kowal K; Rojewska J; Bodzenta-Lukaszyk A; Siergiejko Z; Sierakowska M; Sierakowski S
    Ann Rheum Dis; 2005 Sep; 64(9):1343-6. PubMed ID: 16100339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.